George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4x Discry Hdgs Regulatory News (C4XD)

Share Price Information for C4x Discry Hdgs (C4XD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 10.30
Ask: 10.80
Change: 2.575 (27.32%)
Spread: 0.50 (4.854%)
Open: 9.40
High: 12.00
Low: 9.20
Prev. Close: 12.00
C4XD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

5 Apr 2017 12:24

RNS Number : 6815B
C4X Discovery Holdings PLC
05 April 2017
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

C4X DISCOVERY HOLDINGS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

ü

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

03 APRIL 2017

6. Date on which issuer notified:

04 APRIL 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB00BQQ2RV18

0

0

2,441,000

2,441,000

5.3491%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,441,000

5.3491%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

All of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the investments on a discretionary basis.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

The change in the percentage of shares held is due entirely to participation in the placing by C4X Discovery Holdings Plc, the shares from which were admitted to AIM on 03/04/2017.

14. Contact name:

David Clueit,

Hargreave Hale Ltd

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLOKPDBDBKDBQK
Date   Source Headline
25th Jun 20197:00 amRNSC4X Discovery collaboration with PhoreMost
30th Apr 20197:00 amRNSInterim results
18th Mar 20197:00 amRNSNotice of Results
6th Mar 201911:19 amRNSPDMR Shareholdings
15th Jan 201910:28 amRNSResult of AGM
17th Dec 20187:00 amRNSC4X Discovery partnership with Horizon Discovery
11th Dec 201811:48 amRNS2018 Annual Report
6th Dec 20187:00 amRNSC4X Discovery collaboration with E-Therapeutics
29th Nov 20187:00 amRNSDiscovery partnership with GTN Ltd.
27th Nov 20187:00 amRNSDiscovery partnership with LifeArc
21st Nov 20187:00 amRNSFull year results for the year ended 31 July 2018
9th Nov 20187:00 amRNSNotice of Results
22nd Oct 20187:00 amRNSPDMR Shareholding
19th Oct 20184:33 pmRNSExercise of Options and Issue of Equity
16th Oct 20189:45 amRNSGrant of Options and Director Dealing
10th Oct 20183:26 pmRNSNotification of major holdings
10th Oct 20183:22 pmRNSNotification of major holdings
10th Oct 20181:04 pmRNSHoldings in Company
10th Oct 20187:00 amRNSHoldings in Company
5th Oct 201811:11 amRNSResult of General Meeting
5th Oct 201810:29 amRNSProposed Placing, Open Offer and Notice of GM
18th Sep 20184:53 pmRNSResults of Placing
18th Sep 20181:53 pmRNSProposed Placing, Open Offer and Notice of GM
24th Jul 20187:00 amRNSC4X3256 programme awarded $480k NIDA grant
4th Jul 20187:00 amRNSBoard Changes
1st May 20187:00 amRNSCollaboration with e-Therapeutics
17th Apr 201812:50 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSInterim results
10th Apr 20187:00 amRNSNotice of Results
29th Mar 20187:00 amRNSIndivior deal worth up to $294 Million
18th Jan 20182:36 pmRNS2017 Annual Report
16th Jan 201810:46 amRNSResult of AGM
14th Dec 20177:00 amRNSFull year results for the year ended 31 July 2017
12th Dec 20177:00 amRNSNotice of Results
13th Nov 20177:00 amRNSC4XD presents data on Orexin-1 antagonist
20th Sep 201710:04 amRNSHolding(s) in Company
6th Sep 201711:51 amRNSPDMR Shareholdings
5th Sep 20177:00 amRNSBusiness Update
8th Jun 20171:04 pmRNSIssue of Equity
5th Jun 201710:21 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSInterim results for six months ended 31 Jan 2017
18th Apr 20177:00 amRNSNotice of Results
6th Apr 20178:03 amRNSHolding(s) in Company
5th Apr 20175:49 pmRNSHolding(s) in Company
5th Apr 201712:24 pmRNSHoldings in Company
3rd Apr 20175:22 pmRNSHolding(s) in Company
3rd Apr 20175:21 pmRNSHolding(s) in Company
31st Mar 201710:42 amRNSResult of General Meeting and Issue of Equity
14th Mar 20171:30 pmRNSResults of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.